|
OMIM |
Link |
Information gain |
01 |
|
IGAD1
|
[NCBI]
|
0.00347828
|
|
|
r binder deficiency with lactoferrin deficiency
|
[NCBI]
|
0.00257432
|
|
|
CF
|
[NCBI]
|
0.00182555
|
|
|
salivary substance, clostridium botulinum type
|
[NCBI]
|
0.00148718
|
|
|
amobarbital, deficient n-hydroxylation of
|
[NCBI]
|
0.00148718
|
|
|
dermal ridges-off-the-end
|
[NCBI]
|
0.00117647
|
|
|
sjogren syndrome
|
[NCBI]
|
0.000718093
|
|
|
EGF
|
[NCBI]
|
0.000598099
|
|
|
SAL-I
|
[NCBI]
|
0.000337025
|
|
|
MDD
|
[NCBI]
|
0.000290175
|
|
|
SLPI
|
[NCBI]
|
0.000270546
|
|
|
AMY1A
|
[NCBI]
|
0.000260627
|
|
|
PHA1
|
[NCBI]
|
0.000189917
|
|
|
gamma-a-globulin, defect in assembly of
|
[NCBI]
|
0.000168406
|
|
|
SAPX
|
[NCBI]
|
0.000168406
|
|
|
intrinsic factor and r binder, combined congenital deficiency of
|
[NCBI]
|
0.000168406
|
|
|
blood group--private systems
|
[NCBI]
|
0.000168406
|
|
|
sc(1) trait of saliva
|
[NCBI]
|
0.000168406
|
|
|
lymphoblastic transformation, intrinsic defect in
|
[NCBI]
|
0.000168406
|
|
|
blood group--en
|
[NCBI]
|
0.000168406
|
|
|
lymphokine deficiency
|
[NCBI]
|
0.000168406
|
|
|
VIP
|
[NCBI]
|
0.000164335
|
|
|
PRB1
|
[NCBI]
|
0.000145789
|
|
|
SHBG
|
[NCBI]
|
0.0001433
|
|
|
PRH1
|
[NCBI]
|
0.00014121
|
|
|
SACP
|
[NCBI]
|
0.000139225
|
|
|
FUT2
|
[NCBI]
|
0.000133832
|
|
|
secretory component deficiency
|
[NCBI]
|
0.000129203
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
0.000129203
|
|
|
alkaline phosphatase, blood group-associated
|
[NCBI]
|
0.000129203
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
0.000129203
|
|
|
LPO
|
[NCBI]
|
0.000126017
|
|
|
CA6
|
[NCBI]
|
0.000115014
|
|
|
kartagener syndrome
|
[NCBI]
|
0.000114842
|
|
|
methane production
|
[NCBI]
|
0.000114452
|
|
|
thyroid hormonogenesis, genetic defect in, 1
|
[NCBI]
|
0.000114452
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000108466
|
|
|
HTN3
|
[NCBI]
|
9.80376e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
9.7814e-05
|
|
|
FUT1
|
[NCBI]
|
9.53122e-05
|
|
|
r binder protein
|
[NCBI]
|
9.27941e-05
|
|
|
ALB
|
[NCBI]
|
9.2172e-05
|
|
|
AMY2A
|
[NCBI]
|
8.69644e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
8.35259e-05
|
|
|
LADD
|
[NCBI]
|
7.42048e-05
|
|
|
PRB4
|
[NCBI]
|
7.28496e-05
|
|
|
SGD
|
[NCBI]
|
6.3535e-05
|
|
|
PRH2
|
[NCBI]
|
6.26914e-05
|
|
|
CHNG2
|
[NCBI]
|
5.34925e-05
|
|
|
PCTT
|
[NCBI]
|
5.12277e-05
|
|
|
ABO
|
[NCBI]
|
4.77578e-05
|
|
|
salivary esterase
|
[NCBI]
|
4.63858e-05
|
|
|
RNASE3
|
[NCBI]
|
4.43265e-05
|
|
|
PIGR
|
[NCBI]
|
4.30875e-05
|
|
|
AQP5
|
[NCBI]
|
4.06913e-05
|
|
|
SMR3B
|
[NCBI]
|
3.64136e-05
|
|
|
ITPR2
|
[NCBI]
|
3.64136e-05
|
|
|
PROL1
|
[NCBI]
|
3.64136e-05
|
|
|
MUC7
|
[NCBI]
|
3.64136e-05
|
|
|
TNF
|
[NCBI]
|
3.6207e-05
|
|
|
CST5
|
[NCBI]
|
3.26568e-05
|
|
|
STATH
|
[NCBI]
|
3.26568e-05
|
|
|
RA
|
[NCBI]
|
3.2637e-05
|
|
|
SERPINA6
|
[NCBI]
|
3.24933e-05
|
|
|
HP
|
[NCBI]
|
3.14718e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
3.07982e-05
|
|
|
ITPR3
|
[NCBI]
|
3.02211e-05
|
|
|
CHE2
|
[NCBI]
|
3.02211e-05
|
|
|
MUC5B
|
[NCBI]
|
3.02211e-05
|
|
|
VEGF
|
[NCBI]
|
3.01286e-05
|
|
|
GFRA2
|
[NCBI]
|
2.84129e-05
|
|
|
PRB3
|
[NCBI]
|
2.84129e-05
|
|
|
AT
|
[NCBI]
|
2.80243e-05
|
|
|
ANPEP
|
[NCBI]
|
2.69743e-05
|
|
|
CYP1A2
|
[NCBI]
|
2.57799e-05
|
|
|
FUT6
|
[NCBI]
|
2.4759e-05
|
|
|
DCD
|
[NCBI]
|
2.38679e-05
|
|
|
FUT3
|
[NCBI]
|
2.38679e-05
|
|
|
AHSG
|
[NCBI]
|
2.30776e-05
|
|
|
fabry disease
|
[NCBI]
|
2.19558e-05
|
|
|
LCN1
|
[NCBI]
|
2.17235e-05
|
|
|
PAM
|
[NCBI]
|
2.14504e-05
|
|
|
ACHE
|
[NCBI]
|
2.10447e-05
|
|
|
PEPA
|
[NCBI]
|
2.05911e-05
|
|
|
PIP
|
[NCBI]
|
1.96188e-05
|
|
|
CYP11B2
|
[NCBI]
|
1.91799e-05
|
|
|
CST3
|
[NCBI]
|
1.91799e-05
|
|
|
MME
|
[NCBI]
|
1.91799e-05
|
|
|
MPO
|
[NCBI]
|
1.81404e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.77271e-05
|
|
|
AVP
|
[NCBI]
|
1.74347e-05
|
|
|
LDHB
|
[NCBI]
|
1.70146e-05
|
|
|
IGKC
|
[NCBI]
|
1.64242e-05
|
|
|
H6PD
|
[NCBI]
|
1.53808e-05
|
|
|
ACP1
|
[NCBI]
|
1.38793e-05
|
|
|
PCNA
|
[NCBI]
|
1.28295e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.20573e-05
|
|
|
GCCR
|
[NCBI]
|
1.15132e-05
|
|
|
PCI
|
[NCBI]
|
1.11321e-05
|
|
|
LOX
|
[NCBI]
|
1.02203e-05
|
|
|
LCN2
|
[NCBI]
|
1.02203e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.01156e-05
|
|
|
EPO
|
[NCBI]
|
1.00463e-05
|
|
|
MBP
|
[NCBI]
|
8.5257e-06
|
|
|
HMBS
|
[NCBI]
|
7.97944e-06
|
|
|
PWS
|
[NCBI]
|
7.94896e-06
|
|
|
EGFR
|
[NCBI]
|
6.66379e-06
|
|
|
BDNF
|
[NCBI]
|
6.37677e-06
|
|
|
BL
|
[NCBI]
|
5.98304e-06
|
|
|
IL6
|
[NCBI]
|
5.55094e-06
|
|
|
NPY
|
[NCBI]
|
5.22031e-06
|
|
|
CAT
|
[NCBI]
|
4.8942e-06
|
|
|
LDLR
|
[NCBI]
|
4.3499e-06
|
|
|
LPL
|
[NCBI]
|
4.33882e-06
|
|
|
GRP
|
[NCBI]
|
4.12839e-06
|
|
|
CFTR
|
[NCBI]
|
4.05397e-06
|
|
|
SLE
|
[NCBI]
|
4.04933e-06
|
|
|
CEACAM5
|
[NCBI]
|
4.04446e-06
|
|
|
NPPA
|
[NCBI]
|
3.77434e-06
|
|
|
GPI
|
[NCBI]
|
3.61238e-06
|
|
|
TF
|
[NCBI]
|
3.34584e-06
|
|
|
CRH
|
[NCBI]
|
3.22648e-06
|
|
|
KLK3
|
[NCBI]
|
3.0193e-06
|
|
|
APOE
|
[NCBI]
|
1.92896e-06
|
|
|
PRL
|
[NCBI]
|
1.86002e-06
|
|
|
GIP
|
[NCBI]
|
1.28493e-06
|
|
|
ADA
|
[NCBI]
|
8.66147e-07
|
|
|
PD
|
[NCBI]
|
5.70957e-07
|
|
|
CCK
|
[NCBI]
|
4.73552e-07
|
|
|
HGF
|
[NCBI]
|
3.68029e-07
|
|
|
FA
|
[NCBI]
|
2.36933e-07
|
|
|
FGF7
|
[NCBI]
|
2.03592e-07
|
|
|
POMC
|
[NCBI]
|
1.47405e-07
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.29363e-07
|
|
|
NGFB
|
[NCBI]
|
1.10595e-07
|
|
|
TG
|
[NCBI]
|
8.6729e-08
|
|
|
CD
|
[NCBI]
|
5.95912e-08
|
|
|
TNFRSF11B
|
[NCBI]
|
5.84639e-08
|
|
|
AFP
|
[NCBI]
|
5.19912e-08
|
|
|
IL2
|
[NCBI]
|
2.54201e-08
|
|
|
GAPDH
|
[NCBI]
|
9.70153e-09
|
|
|
PTH
|
[NCBI]
|
1.88901e-09
|
|